Ainnocence

AInnocence is a computational drug discovery platform built to help biotechnology and phArmaceutical teams identify promising therapeutic candidates faster and at lower cost. Founded by a team that combines biomedical science and computer science expertise, the platform focuses on small-molecule and large-molecule design, aiming to shorten the early stages of drug development.

What it does

Ainnocence offers AI-powereD systems that screen vast numbers of chemical compounds and biological molecules in Silico. According to the company, if a research team provides only the sequence Information of a biological target, the platform can evaluate billions of molecules within hours. This APProach is intended to bypass many traditional high-throughput wet-lab experiments, which are often time-consuming and expensive.

Key capabilities

• Small-molecule design: Generates and prioritizes drug-like compounds that may interACT with a given target.
• Large-molecule design: Supports the design of biologics such as antibodies or peptides by modeling molecular interactions.
• RAPId virtual screening: Screens large compound libraries computationally to nARRow down candidates before laboratory testing.
• Target-based workflows: Uses sequence information to initiate discovery campaigns without requiring extensive prior assay data.

Who it is for

The platform is aimed at drug discovery scientists, bioTech Startups, and established pharmaceutical companies that want to accelerate hit identification and lead optimization. It may also appeal to academic research groups exploring novel therapeutic targets. Because the tool is specialized, users typically need a background in computational biology, cheminformatics, or a related field to interpret results effectively.

How to get started

Prospective users can visit the Ainnocence website to learn more about the platform and request a consultation or dEMO. The company likely works directly with research teams to onboard their targets and configure analyses. Exact onboarding steps may vary, so interested parties should contact Ainnocence for details.

Pricing and access caveat

Pricing information for Ainnocence is not publicly listed. As a specialized enterprise tool, access is probably arranged through a commercial agreement, and a trial or pilot may be available upon request. Potential users should confirm current pricing, licensing terms, and Data Security policies directly with the vendor. The platform is web-based and primarily offered in English.